1
|
Mannuel HD, Dawson N, Khan I, Feldman M, Boyle L, Besche M, Smoot J, Engstrom C, Monroe M, Hussain A. Initial results of ongoing phase I/II studies of weekly doxorubicin (Doxo)/docetaxel (Doce) in men with hormone refractory (HRPC) and hormone sensitive prostate cancer (HSPC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.4665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - I. Khan
- Univ of Maryland, Baltimore, MD
| | | | | | | | | | | | | | | |
Collapse
|